Braster S.A. (BRA) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Braster S.A. (BRA) has a cash flow conversion efficiency ratio of -0.048x as of March 2024. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (zł244.00K ≈ $67.15K USD) by net assets (zł-5.04 Million ≈ $-1.39 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Braster S.A. (BRA) defensive interval to measure how many days the company can operate on defensive assets alone.
Braster S.A. - Cash Flow Conversion Efficiency Trend (2011–2023)
This chart illustrates how Braster S.A.'s cash flow conversion efficiency has evolved over time, based on yearly financial data.
Braster S.A. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Braster S.A. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Megapower Makmur TBK PT
JK:MPOW
|
0.022x |
|
Erika Carmel Ltd
TA:BCUR
|
0.113x |
|
Maple Peak Investments Inc
V:MAP
|
-0.062x |
|
Rincon Resources Ltd
AU:RCR
|
-0.029x |
|
Parx Plastics NV
PA:MLPRX
|
N/A |
|
MAST ENERGY DEV. LS -001
F:97D
|
N/A |
|
Ambica Agarbathies & Aroma industries Limited
NSE:AMBICAAGAR
|
0.071x |
|
Optima Prima Metal Sinergi
JK:OPMS
|
-0.004x |
Annual Cash Flow Conversion Efficiency for Braster S.A. (2011–2023)
The table below shows the annual cash flow conversion efficiency of Braster S.A. from 2011 to 2023. For the full company profile with market capitalisation and key ratios, see BRA company net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2023-12-31 | zł-4.43 Million ≈ $-1.22 Million |
zł1.24 Million ≈ $340.17K |
-0.279x | -114.68% |
| 2022-12-31 | zł650.00K ≈ $178.89K |
zł1.24 Million ≈ $340.17K |
1.902x | +298.59% |
| 2021-12-31 | zł1.76 Million ≈ $485.75K |
zł-1.69 Million ≈ $-465.11K |
-0.958x | -85.29% |
| 2020-12-31 | zł7.90 Million ≈ $2.18 Million |
zł-4.08 Million ≈ $-1.12 Million |
-0.517x | +44.24% |
| 2019-12-31 | zł20.79 Million ≈ $5.72 Million |
zł-19.27 Million ≈ $-5.30 Million |
-0.927x | -55.58% |
| 2018-12-31 | zł29.02 Million ≈ $7.99 Million |
zł-17.28 Million ≈ $-4.76 Million |
-0.596x | -0.48% |
| 2017-12-31 | zł48.80 Million ≈ $13.43 Million |
zł-28.93 Million ≈ $-7.96 Million |
-0.593x | -113.65% |
| 2016-12-31 | zł34.84 Million ≈ $9.59 Million |
zł-9.67 Million ≈ $-2.66 Million |
-0.277x | -74.47% |
| 2015-12-31 | zł42.00 Million ≈ $11.56 Million |
zł-6.68 Million ≈ $-1.84 Million |
-0.159x | -100.80% |
| 2014-12-31 | zł8.81 Million ≈ $2.43 Million |
zł-698.00K ≈ $-192.10K |
-0.079x | +83.70% |
| 2013-12-31 | zł5.92 Million ≈ $1.63 Million |
zł-2.88 Million ≈ $-791.61K |
-0.486x | -102.29% |
| 2012-12-31 | zł8.64 Million ≈ $2.38 Million |
zł-2.07 Million ≈ $-570.99K |
-0.240x | +96.62% |
| 2011-12-31 | zł63.73K ≈ $17.54K |
zł-452.66K ≈ $-124.58K |
-7.103x | -- |
About Braster S.A.
Braster S.A. provides in-home breast cancer examination device worldwide. The company offers Braster System, a device that allows every woman to perform breast examination independently at home; and Braster Pro, a certified medical device that supports the process of breast examination in clinical conditions. It also provides automatic interpretation of results of thermographic breast examination… Read more